ZA912489B - Novel t-cell lymphoma cdna clones - Google Patents

Novel t-cell lymphoma cdna clones

Info

Publication number
ZA912489B
ZA912489B ZA912489A ZA912489A ZA912489B ZA 912489 B ZA912489 B ZA 912489B ZA 912489 A ZA912489 A ZA 912489A ZA 912489 A ZA912489 A ZA 912489A ZA 912489 B ZA912489 B ZA 912489B
Authority
ZA
South Africa
Prior art keywords
novel
expressed
proteins
cell
dna sequences
Prior art date
Application number
ZA912489A
Other languages
English (en)
Inventor
Carol L Macleod
L Macleod Carol
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of ZA912489B publication Critical patent/ZA912489B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
ZA912489A 1990-04-13 1991-04-04 Novel t-cell lymphoma cdna clones ZA912489B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50968490A 1990-04-13 1990-04-13

Publications (1)

Publication Number Publication Date
ZA912489B true ZA912489B (en) 1992-01-29

Family

ID=24027673

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA912489A ZA912489B (en) 1990-04-13 1991-04-04 Novel t-cell lymphoma cdna clones

Country Status (22)

Country Link
US (2) US5312733A (ru)
EP (1) EP0527813B1 (ru)
JP (1) JPH05506989A (ru)
KR (1) KR100212371B1 (ru)
AT (1) ATE141105T1 (ru)
AU (1) AU664535B2 (ru)
CA (1) CA2080018C (ru)
DE (1) DE69121240T2 (ru)
DK (1) DK0527813T3 (ru)
ES (1) ES2093100T3 (ru)
FI (1) FI108037B (ru)
GR (1) GR3021478T3 (ru)
HK (1) HK1006726A1 (ru)
IE (1) IE75903B1 (ru)
IL (1) IL97775A (ru)
NO (1) NO307341B1 (ru)
NZ (1) NZ237669A (ru)
PT (1) PT97355B (ru)
RU (1) RU2116346C1 (ru)
SA (1) SA92120348B1 (ru)
WO (1) WO1991016430A1 (ru)
ZA (1) ZA912489B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6784163B1 (en) * 1990-04-13 2004-08-31 Macleod Carol L. Inhibition of cationic amino acid transporter protein and uses thereof
WO1994004567A1 (en) * 1992-08-21 1994-03-03 La Jolla Cancer Research Foundation A matrix-associating dna-protein, nucleic acids encoding the same and methods for detecting the nucleic acids
US5674704A (en) * 1993-05-07 1997-10-07 Immunex Corporation Cytokine designated 4-IBB ligand
US7211259B1 (en) 1993-05-07 2007-05-01 Immunex Corporation 4-1BB polypeptides and DNA encoding 4-1BB polypeptides
US7138500B1 (en) * 1993-05-07 2006-11-21 Immunex Corporation Antibodies to human 4-1BB
US5866329A (en) * 1995-09-27 1999-02-02 Demetriou; Achilles A. Method and probe for detection of gene associated with liver neoplastic disease
US5861248A (en) * 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
US6627199B1 (en) * 1999-07-09 2003-09-30 Amgen Inc Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
US20030096355A1 (en) * 1999-07-09 2003-05-22 Ke Zhang Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
WO2001010908A1 (en) * 1999-08-04 2001-02-15 Amgen Inc. Ntr3, a member of the tnf-receptor supergene family
AU783682B2 (en) * 1999-08-04 2005-11-24 Amgen, Inc. Fhm, a novel member of the TNF ligand supergene family
WO2003027320A2 (en) * 2001-09-24 2003-04-03 University Of Aarhus Methods for diagnosis and treatment of diseases associated with altered expression of pik3r1
EP1913401A4 (en) * 2005-08-03 2009-11-18 Astrazeneca Ab METHOD FOR IDENTIFYING AN AGENT THAT MODULATES TRANSPORTATION OF ARGININE IN A CHONDROCYTE
WO2007056854A1 (en) 2005-11-18 2007-05-24 University Health Network Method of expanding double negative t cells
KR101790647B1 (ko) 2009-06-10 2017-10-26 스티븐 사니그 리서치 인스티튜트 리미티드 표현형적 유연성을 나타내는 세포 제조 방법

Also Published As

Publication number Publication date
JPH05506989A (ja) 1993-10-14
NO923918L (no) 1992-12-01
DE69121240T2 (de) 1997-01-09
EP0527813B1 (en) 1996-08-07
DE69121240D1 (de) 1996-09-12
IE911250A1 (en) 1991-10-23
NO923918D0 (no) 1992-10-08
IL97775A (en) 1998-04-05
US5312733A (en) 1994-05-17
ES2093100T3 (es) 1996-12-16
FI108037B (fi) 2001-11-15
IL97775A0 (en) 1992-06-21
FI924575A (fi) 1992-10-09
GR3021478T3 (en) 1997-01-31
PT97355B (pt) 1998-08-31
AU7745791A (en) 1991-11-11
WO1991016430A1 (en) 1991-10-31
PT97355A (pt) 1991-12-31
CA2080018C (en) 2003-10-14
KR930700657A (ko) 1993-03-15
NO307341B1 (no) 2000-03-20
KR100212371B1 (ko) 1999-08-02
RU2116346C1 (ru) 1998-07-27
EP0527813A1 (en) 1993-02-24
ATE141105T1 (de) 1996-08-15
HK1006726A1 (en) 1999-03-12
AU664535B2 (en) 1995-11-23
EP0527813A4 (en) 1993-05-05
CA2080018A1 (en) 1991-10-14
US5440017A (en) 1995-08-08
FI924575A0 (fi) 1992-10-09
NZ237669A (en) 1992-08-26
IE75903B1 (en) 1997-10-08
DK0527813T3 (da) 1996-12-30
SA92120348B1 (ar) 2004-01-24

Similar Documents

Publication Publication Date Title
IL97775A0 (en) T-cell lymphoma cdna clones
RU2346951C2 (ru) Выделенный полипептид, связывающий рецептор zalpha11-лиганда (варианты), кодирующий его полинуклеотид (варианты), вектор экспрессии (варианты) и клетка-хозяин (варианты)
DE69535375D1 (de) Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper
UA40621C2 (ru) Моноклональное антитело, гибридомная клеточная линия, полипептид (варианты), фрагмент днк (варианты), фармацевтическая композиция, способ получения моноклонального антитела
CA2164984A1 (en) Recombinant disulfide-stabilized polypeptide fragments having binding specificity
EP0281604A4 (en) BINDING MOLECULES WITH SINGLE POLYPEPTIDE CHAIN.
EP0590071A4 (en) Substantially pure receptor like tgf--g(b)1 binding molecules and uses thereof
Nolan et al. Molecular cloning of the cDNA coding for properdin, a positive regulator of the alternative pathway of human complement
GR3019849T3 (en) Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis
IL98024A0 (en) Cd44-surface proteins,dna-sequences coding therefor,polypeptides coded by said dna sequences and diagnostic compositions containing the same
GR3035636T3 (en) Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
CA2461443A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
AU5508396A (en) Pcna binding substance
DE69328114D1 (en) Peptide als diagnose- und therapiemittel für spondyloarthropathien
PT99995A (pt) Processo de preparacao de uma nova proteina de ligacao ao factor de crescimento semelhante a insulina (igfbp-6)
ATE212056T1 (de) Methoden zur herstellung von rna viren aus cdna
ATE281519T1 (de) Klonierung und rekombinante herstellung des crf- rezeptors (crf=corticotropin ausloese faktor)
MacLeod T-cell lymphoma CDNA clones
CA2180957A1 (en) Cloning and recombinant production of crf receptor(s)
RU2004118303A (ru) Быстросозревающие флуоресцирующие белки и способы их применения
Zhang et al. Primary structure of myohemerythrin from Phascolopsis gouldii
EP1820859A3 (en) Methods and compositions for inhibiting neoplastic cell growth
RU97106012A (ru) Новые связывающие рка белки и их использование
Saito et al. Differential expression of the leucocyte